Blogs | Multibagger Shares

April 18, 2026

Cement Sector Analysis Framework Grid with Four Colored Blocks Trader gray Compounder green Drift light Gray Speculator orange on a Dark Blue Background

Cement Sector Analysis Framework: The 8-Factor Checklist Every Indian Value Investor Must Use to Separate Multibagger Cement Stocks from Value Traps in India’s ₹2 Lakh Crore Super-Cycle

A complete 8-factor framework for analysing Indian cement stocks — capacity, region, EBITDA per tonne, balance sheet, and consolidation theme. Live data, no F&O noise, real multibagger hunting.

April 17, 2026

Bar Chart Titled Normalized Earnings Analysis Showing Fy20fy25 Fy25 is Green with Value 16 Others Show 38 32 26 22 19

Normalized Earnings Analysis: How to See Through Cyclical Noise and Find the True Earning Power of Indian Stocks — The Professional Valuation Technique Every Serious Value Investor Must Master

Stop valuing companies on volatile reported earnings. Master the five-step normalization framework that Warren Buffett, Bruce Greenwald, and Howard Marks all use — and see why Titan Biotech's consistent earnings power already passes the test.

April 17, 2026

Infographic Price to sales ps Ratio with a Horizontal Bar Chart from Fy20 to Fy25 Showing Values 38 32 26 22 19 and 16 Fy25 Bar is Green to Highlight the Final Value Captioned multibagger Shares Page with a Subtitle About Undervalued Indian Multibaggers

Price-to-Sales (P/S) Ratio: Ken Fisher’s Revolutionary Valuation Metric That Reveals Undervalued Indian Multibaggers When Earnings Temporarily Collapse — The Forgotten Formula Every Value Investor Must Master in 2026

Ken Fisher's Price-to-Sales (P/S) ratio is the valuation tool Indian investors must master when earnings are temporarily distorted. Complete framework: thresholds, pitfalls, quality filters, and how to triangulate P/S with P/E, P/B, EV/EBITDA and DCF — with Titan Biotech illustrating the Super Stock quality envelope.

April 17, 2026

Management Compensation vs Profit

Titan Biotech's FY25 board paid ₹4.56 Cr across 5 directors — on zero raises during a down year. We decode Section 197, the CEO-to-median ratio (20.84:1), and the four-point forensic checklist every Indian value investor must apply to small-cap governance.